TerminatedNot Applicable

Screening Study to Identify Patients With Complement Factor I Deficiencies

Stopped: Enrollment

United States113 participantsStarted 2021-07-21

Plain-language summary

This is screening study to identify patients with Complement Factor I deficiencies. The primary objective is to identify participants with CFI deficiencies and assess the prevalence in the screened population.

Who can participate

Age range6 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. A male or female ≥6 months of age who has been diagnosed with a complement-mediated disease in which a reasonable etiological association with CFI deficiency has been reported
✓. Affirmation of participant's informed consent or LAR's willingness to provide informed consent with signature confirmation before any study-related activities. (Study-related activities are any procedures that would not have been performed during normal clinical management of the participant.) The participant (if a minor) must be willing to give written informed assent if the minor is within the age groups 7 to 11 years old and 12 to 17 years old.

What they're measuring

Complement Factor I Deficiency Identification

Timeframe: At Screening

Trial details

NCT IDNCT05072912

SponsorCatalyst Biosciences

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-11-23

View on ClinicalTrials.gov More Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I Deficiency trials